Quantification of asymptomatic infections is fundamental for effective public health responses
to the COVID-19 pandemic. Discrepancies regarding the extent of asymptomaticity have …

The disease costs of sociality have largely been understood through the link between group
size and transmission. However, infectious disease spread is driven primarily by the social …

The novel coronavirus outbreak (COVID-19) in mainland China has rapidly spread across
the globe. Within 2 mo since the outbreak was first reported on December 31, 2019, a total of …

Since the emergence of coronavirus disease 2019 (COVID-19), unprecedented movement
restrictions and social distancing measures have been implemented worldwide. The …

In the wake of community coronavirus disease 2019 (COVID-19) transmission in the United
States, there is a growing public health concern regarding the adequacy of resources to treat …

The durability of vaccine-mediated immunity to SARS-CoV-2, the durations to breakthrough
infection, and the optimal timings of booster vaccination are crucial knowledge for pandemic …

Two of the Coronavirus Disease 2019 (COVID-19) vaccines currently approved in the United
States require 2 doses, administered 3 to 4 weeks apart. Constraints in vaccine supply and …

Background More contagious variants of SARS-CoV-2 have emerged around the world,
sparking concerns about impending surge in cases and severe outcomes. Despite the …

Disease risk is a potential cost of group living. Although modular organization is thought to
reduce this cost in animal societies, empirical evidence toward this hypothesis has been …

The factors that drive spatial heterogeneity and diffusion of pandemic influenza remain debated.
We characterized the spatiotemporal mortality patterns of the 1918 influenza pandemic …